HUP0201287A2 - Eozinofilek számának növekedésével járó betegségek megelőzésére és kezelésére alkalmas, hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmény - Google Patents
Eozinofilek számának növekedésével járó betegségek megelőzésére és kezelésére alkalmas, hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítményInfo
- Publication number
- HUP0201287A2 HUP0201287A2 HU0201287A HUP0201287A HUP0201287A2 HU P0201287 A2 HUP0201287 A2 HU P0201287A2 HU 0201287 A HU0201287 A HU 0201287A HU P0201287 A HUP0201287 A HU P0201287A HU P0201287 A2 HUP0201287 A2 HU P0201287A2
- Authority
- HU
- Hungary
- Prior art keywords
- active ingredient
- eosinphilia
- preventive
- various
- related diseases
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 239000003601 chymase inhibitor Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 230000003449 preventive effect Effects 0.000 title 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1
- 229940126585 therapeutic drug Drugs 0.000 title 1
- 229940119334 Chymase inhibitor Drugs 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya hatóanyagként kimázinhibítort tartalmazó gyógyszer,amely biztonságosan alkalmazható az eozinofilek számának növekedéséveljáró betegségek megelőzésére vagy kezelésére, és amely gátolja abetegség kifejlődését, gátolja a szövődmények kifejlődését és javítjaa beteg életminőségét. A hatóanyag kimázinhibítor egy (I) általánosképletű vegyület, vagy annak gyógyászatilag elfogadható sója, ahol R1,R2, R3 és X különböző alifás és aromás csoportokat, A benzolgyűrűtjelent. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000050487 | 2000-02-22 | ||
PCT/JP2001/001322 WO2001062293A1 (fr) | 2000-02-22 | 2001-02-22 | Medicaments preventifs ou therapeutiques contenant des inhibiteurs de chymase en tant que principe actif, pour traiter diverses maladies associees a l'eosinophilie |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0201287A2 true HUP0201287A2 (hu) | 2002-12-28 |
HUP0201287A3 HUP0201287A3 (en) | 2003-02-28 |
Family
ID=18572266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0201287A HUP0201287A3 (en) | 2000-02-22 | 2001-02-22 | Preventive or therapeutic drugs for various eosinphilia-related diseases containing quinazoline derivative chymase inhibitors as the active ingredient |
Country Status (11)
Country | Link |
---|---|
US (1) | US6677344B2 (hu) |
EP (1) | EP1174151B1 (hu) |
KR (1) | KR20010109526A (hu) |
CN (1) | CN1245978C (hu) |
AT (1) | ATE352317T1 (hu) |
AU (1) | AU3413501A (hu) |
CA (1) | CA2365606A1 (hu) |
DE (1) | DE60126199T2 (hu) |
ES (1) | ES2275652T3 (hu) |
HU (1) | HUP0201287A3 (hu) |
WO (1) | WO2001062293A1 (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001062292A1 (fr) | 2000-02-22 | 2001-08-30 | Suntory Limited | Medicaments preventifs ou therapeutiques pour traiter la fibrose et contenant des inhibiteurs de chymase comme ingredients actifs |
AU3413601A (en) | 2000-02-22 | 2001-09-03 | Daiichi Asubio Pharma Co., Ltd. | Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
KR101278522B1 (ko) | 2004-12-02 | 2013-06-25 | 다이이찌 산쿄 가부시키가이샤 | 7원환 화합물 및 그 제조법 및 의약 용도 |
CN101495463B (zh) | 2006-05-31 | 2012-08-15 | 第一三共株式会社 | 7-元环化合物、其制备方法和药物用途 |
DE102009043745A1 (de) | 2009-09-30 | 2011-04-07 | Carl Zeiss Microlmaging Gmbh | Spektraldetektor mit variabler Filterung durch räumliche Farbtrennung und Laser-Scanning- Mikroskop |
JP5676480B2 (ja) | 2009-12-25 | 2015-02-25 | 第一三共株式会社 | 7員環化合物並びにその医薬用途 |
JP7072586B2 (ja) | 2017-05-24 | 2022-05-20 | ザ ユニバーシティ オブ クィーンズランド | 新規な化合物及び使用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6351335A (ja) | 1986-08-20 | 1988-03-04 | Fuji Oil Co Ltd | 肥満細胞脱顆粒抑制剤 |
US5199279A (en) | 1991-08-13 | 1993-04-06 | Reynolds Martin M | Drum contact freezer system and method |
JPH05294930A (ja) * | 1992-04-21 | 1993-11-09 | Yoshitomi Pharmaceut Ind Ltd | スチリル化合物 |
WO1993025574A1 (en) | 1992-06-12 | 1993-12-23 | Pfizer Inc. | Inhibitors of angiotensin i chymase(s) including human heart chymase |
HU218381B (hu) | 1993-05-12 | 2000-08-28 | E.I. Du Pont De Nemours And Co. | 4-(3H)-kinazolin-származékok, azokat hatóanyagként tartalmazó fungicid készítmények és eljárás a készítmények alkalmazására |
AU3086095A (en) | 1994-07-29 | 1996-03-04 | Suntory Limited | Imidazolidine derivative and use thereof |
CA2163399A1 (en) | 1994-11-24 | 1996-05-25 | Katsuhiro Kawano | Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor |
KR100400639B1 (ko) | 1995-04-27 | 2003-12-31 | 미쯔비시 웰 파마 가부시키가이샤 | 복소환식아미드화합물및그의의약용도 |
US5596111A (en) | 1995-06-05 | 1997-01-21 | North Dakota State University | Method for preparation of carboxylic acids |
DE69622148T2 (de) | 1995-09-28 | 2002-10-31 | Suntory Ltd Osaka | Chinazozin derivate und deren verwendung |
CN1169791C (zh) * | 1996-09-06 | 2004-10-06 | 日本化药株式会社 | 新颖的乙酰胺衍生物和蛋白酶抑制剂 |
JPH1087493A (ja) * | 1996-09-18 | 1998-04-07 | Shionogi & Co Ltd | セフェム系化合物を含有するキマーゼ阻害剤 |
JPH10101666A (ja) * | 1996-10-02 | 1998-04-21 | Shionogi & Co Ltd | 新規ベンゾオキサシクロトリデシン化合物およびそれを含有する医薬組成物 |
CN1088706C (zh) | 1996-10-25 | 2002-08-07 | 卫福有限公司 | 新型杂环酰胺化合物及其医药用途 |
JPH10245384A (ja) * | 1997-03-05 | 1998-09-14 | Teijin Ltd | 新規トリアジンスルホン誘導体 |
CA2321146A1 (en) | 1998-02-17 | 1999-08-19 | Nippon Kayaku Kabushiki Kaisha | Novel acetamide derivative and use thereof |
JPH11246437A (ja) * | 1998-03-05 | 1999-09-14 | Yoshitomi Pharmaceut Ind Ltd | 消化管粘膜保護剤 |
AU772771B2 (en) * | 1998-08-21 | 2004-05-06 | Daiichi Asubio Pharma Co., Ltd. | Quinazoline derivatives and pharmaceutical applications thereof |
JP4491866B2 (ja) * | 1999-09-30 | 2010-06-30 | 三菱化学株式会社 | アシルスルホンアミド誘導体 |
KR20010100004A (ko) | 1999-11-01 | 2001-11-09 | 도리이 신이치로 | 키마제 억제 물질을 함유하여 이루어진 혈관 지질 침착방지제 |
WO2001062292A1 (fr) | 2000-02-22 | 2001-08-30 | Suntory Limited | Medicaments preventifs ou therapeutiques pour traiter la fibrose et contenant des inhibiteurs de chymase comme ingredients actifs |
AU3413601A (en) | 2000-02-22 | 2001-09-03 | Daiichi Asubio Pharma Co., Ltd. | Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
-
2001
- 2001-02-22 EP EP01906225A patent/EP1174151B1/en not_active Expired - Lifetime
- 2001-02-22 US US09/959,358 patent/US6677344B2/en not_active Expired - Fee Related
- 2001-02-22 DE DE60126199T patent/DE60126199T2/de not_active Expired - Lifetime
- 2001-02-22 KR KR1020017013380A patent/KR20010109526A/ko not_active Application Discontinuation
- 2001-02-22 AU AU34135/01A patent/AU3413501A/en not_active Abandoned
- 2001-02-22 ES ES01906225T patent/ES2275652T3/es not_active Expired - Lifetime
- 2001-02-22 HU HU0201287A patent/HUP0201287A3/hu unknown
- 2001-02-22 CN CNB018007724A patent/CN1245978C/zh not_active Expired - Fee Related
- 2001-02-22 CA CA002365606A patent/CA2365606A1/en not_active Abandoned
- 2001-02-22 WO PCT/JP2001/001322 patent/WO2001062293A1/ja active IP Right Grant
- 2001-02-22 AT AT01906225T patent/ATE352317T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2275652T3 (es) | 2007-06-16 |
HUP0201287A3 (en) | 2003-02-28 |
DE60126199D1 (de) | 2007-03-15 |
EP1174151B1 (en) | 2007-01-24 |
CA2365606A1 (en) | 2001-08-30 |
EP1174151A1 (en) | 2002-01-23 |
EP1174151A4 (en) | 2003-01-22 |
DE60126199T2 (de) | 2008-02-28 |
ATE352317T1 (de) | 2007-02-15 |
CN1245978C (zh) | 2006-03-22 |
US6677344B2 (en) | 2004-01-13 |
WO2001062293A1 (fr) | 2001-08-30 |
KR20010109526A (ko) | 2001-12-10 |
CN1366459A (zh) | 2002-08-28 |
US20020187989A1 (en) | 2002-12-12 |
AU3413501A (en) | 2001-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201284A2 (hu) | Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére | |
NO20051263L (no) | Ny anvendelse av benzotiazolderivater | |
AR022665A1 (es) | Compuestos farmaceuticamente activos | |
ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
SE0202462D0 (sv) | Novel use | |
GEP20053675B (en) | Pyridazinone Aldose Reductase Inhibitors | |
NO20022014L (no) | En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon | |
HUP0203325A2 (hu) | Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
UA90858C2 (ru) | Композиция с контролируемым высвобождением варденафила | |
DE69206345T2 (de) | Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten. | |
HUP0203971A2 (hu) | Imidazoimidazolok és -triazolok mint gyulladásellenes szerek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
UY27592A1 (es) | Nuevo uso | |
NO20024014D0 (no) | Ny bruk av fenylheteroalkylaminderivater | |
DE59401401D1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
SE9901573D0 (sv) | New compounds | |
HUP0402577A2 (hu) | Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra | |
HUP0202745A2 (hu) | Profilaktikus és terápiás szerek szembetegségek kezelésére | |
HUP0302068A2 (hu) | COX-2 inhibitorok alkalmazása immundeficienciával járó rendellenességek kezelésére vagy megelőzésére és ezeket tartalmazó gyógyszerkészítmények | |
IS8096A (is) | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum | |
HUP0201287A2 (hu) | Eozinofilek számának növekedésével járó betegségek megelőzésére és kezelésére alkalmas, hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmény | |
HUP0201282A2 (hu) | Hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmények dermatitisz megelőzésére és kezelésére | |
ATE447953T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
TR200103144T2 (tr) | Yeni bileşikler | |
HUP0401798A2 (hu) | Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására | |
HUP0302620A2 (hu) | Új cukorbetegség-ellenes kombinációs gyógyszerkészítmények és eljárás ezek előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |